A Novel OGR1 (GPR68) Inhibitor Attenuates Inflammation in Murine Models of Colitis
Background and Aims: Local extracellular acidification is associated with several conditions, such as ischemia, cancer, metabolic disease, respiratory diseases, and inflammatory bowel disease (IBD). Several recent studies reported a link between IBD and a family of pH-sensing G protein-coupled recep...
Main Authors: | Cheryl de Vallière, Katharina Bäbler, Philipp Busenhart, Marlene Schwarzfischer, Chiaki Maeyashiki, Cordelia Schuler, Kirstin Atrott, Silvia Lang, Marianne R. Spalinger, Michael Scharl, Pedro A. Ruiz-Castro, Martin Hausmann, Gerhard Rogler |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2021-07-01
|
Series: | Inflammatory Intestinal Diseases |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/517474 |
Similar Items
-
OGR1 (GPR68) and TDAG8 (GPR65) Have Antagonistic Effects in Models of Colonic Inflammation
by: Leonie Perren, et al.
Published: (2023-10-01) -
Whole body deletion of Gpr68 does not change hematopoietic stem cell function
by: Xiaofei He, et al.
Published: (2020-08-01) -
GPR35 as a novel therapeutic target
by: Amanda eMacKenzie, et al.
Published: (2011-11-01) -
Evolution of vertebrate GnRH receptors from the perspective of a basal vertebrate
by: Stacia A Sower, et al.
Published: (2012-11-01) -
Mouse Mutants of <i>Gpr37</i> and <i>Gpr37l1</i> Receptor Genes: Disease Modeling Applications
by: Marzia Massimi, et al.
Published: (2022-04-01)